FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4491511000001104: Bextra 20mg tablets (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18212101000001119 Bextra 20mg tablets (Pfizer Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
18212201000001114 Bextra 20mg tablets (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bextra 20mg tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Bextra 20mg tablets (Pfizer Ltd) Is a Product containing precisely valdecoxib 20 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Bextra 20mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bextra 20mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Bextra 20mg tablets (Pfizer Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Bextra 20mg tablets (Pfizer Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Bextra 20mg tablets (Pfizer Ltd) Has active ingredient Valdecoxib false Inferred relationship Existential restriction modifier
Bextra 20mg tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bextra 20mg tablets (Pfizer Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Bextra 20mg tablets (Pfizer Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Bextra 20mg tablets (Pfizer Ltd) Is a Bextra true Inferred relationship Existential restriction modifier
Bextra 20mg tablets (Pfizer Ltd) Has specific active ingredient Valdecoxib true Inferred relationship Existential restriction modifier
Bextra 20mg tablets (Pfizer Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Bextra 20mg tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bextra 20mg tablets (Pfizer Ltd) 30 tablet Is pack of False Bextra 20mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier
Bextra 20mg tablets (Pfizer Ltd) 30 tablet Has AMP True Bextra 20mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start